机构:[1]Department of general surgery, The Third People’s Hospital of Chengdu & the Affiliated Hospital of Southwest Jiaotong University & the second medical school of Chengduaffiliated to Chongqing medical university, Chengdu, Sichuan 610031, China[2]Erasmus MC Cancer Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, TheNetherlands[3]Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China[4]Guangzhou Regenerative Medicine and HealthGuangdong Laboratory, Bioland Laboratory, Guangzhou 510005, China
第一作者机构:[1]Department of general surgery, The Third People’s Hospital of Chengdu & the Affiliated Hospital of Southwest Jiaotong University & the second medical school of Chengduaffiliated to Chongqing medical university, Chengdu, Sichuan 610031, China[2]Erasmus MC Cancer Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, TheNetherlands
共同第一作者:
通讯作者:
通讯机构:[2]Erasmus MC Cancer Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, TheNetherlands[3]Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China[4]Guangzhou Regenerative Medicine and HealthGuangdong Laboratory, Bioland Laboratory, Guangzhou 510005, China
推荐引用方式(GB/T 7714):
Yang Qin,Wang Ling,Liu Jiaye,et al.Targeting the complex I and III of mitochondrial electron transport chain as a potentially viable option in liver cancer management.[J].Cell death discovery.2021,7(1):293.doi:10.1038/s41420-021-00675-x.
APA:
Yang Qin,Wang Ling,Liu Jiaye,Cao Wanlu,Pan Qiuwei&Li Meng.(2021).Targeting the complex I and III of mitochondrial electron transport chain as a potentially viable option in liver cancer management..Cell death discovery,7,(1)
MLA:
Yang Qin,et al."Targeting the complex I and III of mitochondrial electron transport chain as a potentially viable option in liver cancer management.".Cell death discovery 7..1(2021):293